2 Questions 3 Answers 0 Followers
Questions related from Divyanshu Prajapati
What are the practical challenges in use of novel intravenous P2Y12 receptor inhibitor 'Cangrelor' in adjunct to PCI? What are the advantages and disadvantages as compared to other anti-platelets?
18 January 2022 4,849 0 View
Subjects suffering from Pneumonia will be recruited in a trial??. what are the inclusion criteria?
23 July 2018 3,539 3 View
